SciELO - Scientific Electronic Library Online

 
vol.87 issue2Shared Governance and Reasonableness as Ethical Contributions to Health PolicyValidation of the Copenhagen Burnout Inventory to Assess Professional Burnout in Spain author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista Española de Salud Pública

On-line version ISSN 2173-9110Print version ISSN 1135-5727

Abstract

CANO-BLANQUER, Diego  and  GRUPO DE ESTUDIO DE LA AUTOMONITORIZACION GLUCEMICA et al. Prevalence and Associated Factors in Self-Monitoring of Blood Glucose in Noninsulin-treated Type 2 Diabetes Patients in the Valencia Community, Spain. Rev. Esp. Salud Publica [online]. 2013, vol.87, n.2, pp.149-163. ISSN 2173-9110.  https://dx.doi.org/10.4321/S1135-57272013000200005.

Background: Self-monitoring of blood glucose (SMBG) in noninsulin-treated type 2 diabetes patients (T2DM) is a controversial topic. We aimed to describe the SMBG prevalence in noninsulin-treated (NIT) T2DM patients in the Valencia Community (VC) and to analyze factors associated with their use. Method: Cross-sectional study with 573 NIT-T2DM patients from 83 primary care surgeries. Electronic medical records and patient interview were used. We examine associations among patient, doctors and organizational characteristics, and the SMBG indication. Results: 289 (50.4%) of the 573 NIT-T2DM patients used SMBG. In the multivariable analysis SMBG use was associated with age (OR:2.3 for 65-84 and 6.0 for <65 years vs 85+ years old)) the length from diagnosis (OR:2.2 for 10-15 years vs 0-5 years), the number of OAAs prescribed (OR:2.5, 4.1 and 5.7 for 1, 2 or 3+ OAAs vs no treatment with OAAs) and type (with more SMBG prescribed in patients with sulfonylureas and glitazones), glycated haemoglobin figures (OR: 1.9 y 1.6 for 7-8 and >8, vs <7), sedentary behaviour (OR:1.6), obesity (OR:1.5), and housewife status, and chronic respiratory disease antecedents (OR:0.5). After controlling these factors, SMBG use was also associated with the length of doctor's professional practice and some healthcare departments. Conclusions: In the Valencia Community the SMBG use in noninsulin-treated T2DM patients is strongly associated with clinic patient' characteristics, but some non-clinical factors explain part of the variance in their utilization.

Keywords : Diabetes Mellitus; Type 2; Blood Glucose Self-Monitoring; Drug utilization; Hypoglycemic Agents; Cross-Sectional Studies; Spain.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License